Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
27.50
-0.15 (-0.54%)
Feb 4, 2026, 3:00 PM CST

SHA:603351 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,3051,2871,1521,1031,032729.59
Other Revenue
9.949.944.218.3610.246.47
1,3151,2971,1561,1111,042736.06
Revenue Growth (YoY)
-0.97%12.19%4.04%6.59%41.60%-16.43%
Cost of Revenue
925.73938.49842.97810.66762.68513.45
Gross Profit
388.9358.26312.87300.36279.63222.62
Selling, General & Admin
122.6115.84121.5126.32107.5372.8
Research & Development
84.8571.5655.6453.8740.7334.83
Other Operating Expenses
1.921.253.237.66.775.76
Operating Expenses
209.89188.99180.67183.31157.17114.63
Operating Income
179.01169.27132.2117.04122.46107.99
Interest Expense
-11.65-13.84-15.25-12.48-7.04-5
Interest & Investment Income
0.620.930.780.631.478.5
Currency Exchange Gain (Loss)
1.541.540.532.48-0.51-0.92
Other Non Operating Income (Expenses)
-0.88-0.48-0.03-0.2-0.710.03
EBT Excluding Unusual Items
168.64157.42118.23107.47115.67110.59
Gain (Loss) on Sale of Investments
4.24121.44-0.111.74.24
Gain (Loss) on Sale of Assets
-0.15-0.17-0.18-0.1-0.18-0.83
Asset Writedown
1.38-----
Other Unusual Items
2.872.871.955.591.544.28
Pretax Income
176.98172.13121.44112.85118.74118.28
Income Tax Expense
31.0726.9312.3318.4218.5917.83
Earnings From Continuing Operations
145.91145.21109.1194.43100.15100.45
Net Income to Company
145.91145.21109.1194.43100.15100.45
Minority Interest in Earnings
1.681.223.080.61.22-
Net Income
147.59146.42112.295.03101.37100.45
Net Income to Common
147.59146.42112.295.03101.37100.45
Net Income Growth
0.52%30.50%18.07%-6.26%0.92%-21.59%
Shares Outstanding (Basic)
135136135132133130
Shares Outstanding (Diluted)
135136135134133130
Shares Change (YoY)
-0.43%0.29%1.00%0.35%2.25%1.83%
EPS (Basic)
1.091.080.830.720.760.77
EPS (Diluted)
1.091.080.830.710.760.77
EPS Growth
0.95%30.12%16.90%-6.58%-1.30%-23.00%
Free Cash Flow
146.9170.3447.17-124.91-247.16-189.13
Free Cash Flow Per Share
1.081.260.35-0.93-1.85-1.45
Dividend Per Share
0.4000.4000.3000.2800.3000.300
Dividend Growth
33.33%33.33%7.14%-6.67%--6.66%
Gross Margin
29.58%27.63%27.07%27.03%26.83%30.24%
Operating Margin
13.62%13.05%11.44%10.54%11.75%14.67%
Profit Margin
11.23%11.29%9.71%8.55%9.73%13.65%
Free Cash Flow Margin
11.17%13.14%4.08%-11.24%-23.71%-25.70%
EBITDA
314.85276.06200.26180.62162.12142.33
EBITDA Margin
23.95%21.29%17.33%16.26%15.55%19.34%
D&A For EBITDA
135.84106.7968.0663.5839.6634.34
EBIT
179.01169.27132.2117.04122.46107.99
EBIT Margin
13.62%13.05%11.44%10.54%11.75%14.67%
Effective Tax Rate
17.55%15.64%10.15%16.32%15.65%15.08%
Revenue as Reported
1,3151,2971,1561,1111,042736.06
Advertising Expenses
-1.091.820.390.610.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.